Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19

Nadir Arber(Unknown), F. Raffi(Inserm), Annie Duffy(Kingsley House), Adrián Curran(Lexington City Schools), Carlos Lumbreras(Marqués de Valdecilla University Hospital), Richard Haubrich(University of California San Diego), Àlex Soriano(Instituto de Salud Carlos III), Nathalie De Castro(Inserm), Lourdes Mateu, Pierre‐Olivier Sellier(Hôpital Lariboisière), Anton Pozniak, Essy Mozaffari(Gilead Sciences (United States)), Casper Rokx(Erasmus MC), Pallav L. Shah(Guy's and St Thomas' NHS Foundation Trust), Lambert Assoumou(Inserm), Paul Hodgkins(Takeda (United States)), Ameet Bakhai(Chase Farm Hospital), Carl Fletcher(Kingsley House), Vicente Estrada(Instituto de Salud Carlos III)
Infectious Diseases Now
July 14, 2023
Cited by 1


Related Papers